Skip to content
Menu

Head-to-head dispatch

Kina vs VyrarX

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Dispatch #227
Kina

Kina is a menopause-care telehealth platform where GLP-1 is the weight-loss treatment, offered alongside HRT, peptide, and compounded options for menopause symptoms.

$179/mo (starting dose, plus a separate fee, compounded) sema · $179/mo (starting dose, compounded) tirz · Verified June 28, 2026

Marked down on: Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro

vs
Dispatch #84Desk pick
VyrarX

VyrarX is a LegitScript-certified telehealth platform offering compounded semaglutide (from $179/month) and compounded tirzepatide (from $329/month) via weekly injection, with provider messaging and nutrition coaching included — and no ladder published behind either "from".

From $179/mo (compounded; the site publishes no ladder, dose banding or term behind the word "from") sema · From $329/mo (compounded; the site publishes no ladder, dose banding or term behind the word "from") tirz · Verified August 29, 2026

Marked down on: Both prices are "from" figures with nothing behind them — no ladder, no dose banding, no plan lengths — on a site whose own badge reads "Transparent pricing"

VyrarX takes this head-to-head with the higher Desk Score, 78/100 (C+) against 65/100 (C) for Kina. Kina still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

Kina

65/100

C

Overall

VyrarX

78/100

C+

Price transparency

78
78

State access

24
78

Molecule range

66
66

Onboarding speed

71
82

Support responsiveness

80
88

Licensing & trust

86
79

The spec sheet

FieldKinaVyrarX
Semaglutide$179/mo (starting dose, plus a separate fee, compounded)From $179/mo (compounded; the site publishes no ladder, dose banding or term behind the word "from")
Tirzepatide$179/mo (starting dose, compounded)From $329/mo (compounded; the site publishes no ladder, dose banding or term behind the word "from")
CoverageNot listed on Kina's site (checked June 28, 2026)47 states (not California, South Carolina or New Jersey)
Brand-nameCompounded onlyCompounded only
Oral optionInjectable onlyInjectable only
Best forWomen in menopause wanting GLP-1 weight care alongside HRT, from board-certified physicians.Readers outside California, South Carolina and New Jersey who want provider messaging and nutrition coaching bundled in, and will complete a five-minute intake to learn what the price becomes at their dose.
Desk Score65/100C78/100C+

The verdict

Desk pick — VyrarX

VyrarX takes this head-to-head with the higher Desk Score, 78/100 (C+) against 65/100 (C) for Kina. Kina still holds its ground where its strengths line up with yours.

Choose Kina if…

Women in menopause wanting GLP-1 weight care alongside HRT, from board-certified physicians.

$179/mo (starting dose, plus a separate fee, compounded) sema · $179/mo (starting dose, compounded) tirz

Choose VyrarX if…

Readers outside California, South Carolina and New Jersey who want provider messaging and nutrition coaching bundled in, and will complete a five-minute intake to learn what the price becomes at their dose.

From $179/mo (compounded; the site publishes no ladder, dose banding or term behind the word "from") sema · From $329/mo (compounded; the site publishes no ladder, dose banding or term behind the word "from") tirz · 47 states (not California, South Carolina or New Jersey)

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Kina · VyrarX.

Also here

CoreAge Rx tops every dispatch at 94/100

Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: one price at every dose, both molecules, all 50 states — but the $99 and $149 figures are 12-month plans paid up front, not a monthly bill.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.